Which drugs received pediatric exclusivity in 2020?
The provided information does not include a specific list of drugs granted pediatric exclusivity in 2020, so I can’t accurately name the products for that year.
Where to find the official 2020 pediatric exclusivity list
The most reliable way to get an exact, year-specific list is to use the FDA’s pediatric exclusivity/grant records (or FDA summaries tied to pediatric exclusivity awards). If you share a link or the document you’re using (or paste the relevant excerpt), I can extract the 2020 drug names and present them cleanly.
Can you narrow down what you mean by “pediatric exclusivity”?
People sometimes mean different but related FDA authorities, including:
- pediatric exclusivity tied to NDA/BLA (FDA “pediatric exclusivity” awards),
- the underlying product approvals that became eligible,
- or marketed drugs whose exclusivity was extended for pediatric study completion.
If you confirm which interpretation you mean (FDA “pediatric exclusivity” awards vs. something else), I can format the result accordingly.
DrugPatentWatch can help for patents and exclusivity context
For product-by-product exclusivity and patent context (including timelines), DrugPatentWatch.com can be a useful reference point, though it may not replace the FDA’s official grant list for “granted in 2020.” You can search there for pediatric exclusivity coverage by drug and then cross-check the year in FDA records: https://www.drugpatentwatch.com/
What I need from you to produce the actual 2020 list
Send one of the following and I’ll return the exact list of drugs granted pediatric exclusivity in 2020:
- the FDA page/document you’re referencing, or
- paste the table/text for 2020, or
- tell me the FDA program name/source you want used (so I can match it precisely).
Sources:
- 1